Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Saito A, Ballinger MD, Pletnikov MV, Wong DF, Kamiya A.

Neurobiol Dis. 2013 May;53:10-7. doi: 10.1016/j.nbd.2012.11.020. Epub 2012 Dec 7. Review.

2.

Cannabis and Endocannabinoid Signaling in Epilepsy.

Katona I.

Handb Exp Pharmacol. 2015;231:285-316. doi: 10.1007/978-3-319-20825-1_10. Review.

PMID:
26408165
3.

Therapeutic potential of cannabinoids in schizophrenia.

Kucerova J, Tabiova K, Drago F, Micale V.

Recent Pat CNS Drug Discov. 2014 Apr;9(1):13-25. Review.

PMID:
24605939
4.

Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.

Müller-Vahl KR, Emrich HM.

Expert Rev Neurother. 2008 Jul;8(7):1037-48. doi: 10.1586/14737175.8.7.1037. Review.

PMID:
18590475
5.

Endocannabinoid biosynthesis and inactivation, from simple to complex.

Muccioli GG.

Drug Discov Today. 2010 Jun;15(11-12):474-83. doi: 10.1016/j.drudis.2010.03.007. Epub 2010 Mar 19. Review.

PMID:
20304091
6.

The endocannabinoid system in ageing: a new target for drug development.

Paradisi A, Oddi S, Maccarrone M.

Curr Drug Targets. 2006 Nov;7(11):1539-52. Review.

PMID:
17100593
7.

Therapeutic potential of the endocannabinoid system in the brain.

Ramos JA, González S, Sagredo O, Gómez-Ruiz M, Fernández-Ruiz J.

Mini Rev Med Chem. 2005 Jul;5(7):609-17. Review.

PMID:
16026307
8.

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.

Hwang J, Adamson C, Butler D, Janero DR, Makriyannis A, Bahr BA.

Life Sci. 2010 Apr 10;86(15-16):615-23. doi: 10.1016/j.lfs.2009.06.003. Epub 2009 Jun 13. Review.

9.

Review article: the endocannabinoid system in liver disease, a potential therapeutic target.

Basu PP, Aloysius MM, Shah NJ, Brown RS Jr.

Aliment Pharmacol Ther. 2014 Apr;39(8):790-801. doi: 10.1111/apt.12673. Epub 2014 Feb 24. Review.

10.

Cannabinoids and the gut: new developments and emerging concepts.

Izzo AA, Sharkey KA.

Pharmacol Ther. 2010 Apr;126(1):21-38. doi: 10.1016/j.pharmthera.2009.12.005. Epub 2010 Feb 1. Review.

PMID:
20117132
11.

The endocannabinoid system as a target for the treatment of cannabis dependence.

Clapper JR, Mangieri RA, Piomelli D.

Neuropharmacology. 2009;56 Suppl 1:235-43. doi: 10.1016/j.neuropharm.2008.07.018. Epub 2008 Jul 19. Review.

12.

Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

Vemuri VK, Janero DR, Makriyannis A.

Physiol Behav. 2008 Mar 18;93(4-5):671-86. Epub 2007 Nov 21. Review.

13.

The endocannabinoid system and pain.

Guindon J, Hohmann AG.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):403-21. Review.

14.

Cannabinoids, endocannabinoids, and cancer.

Hermanson DJ, Marnett LJ.

Cancer Metastasis Rev. 2011 Dec;30(3-4):599-612. doi: 10.1007/s10555-011-9318-8. Review.

15.

Role of cannabis and endocannabinoids in the genesis of schizophrenia.

Fernandez-Espejo E, Viveros MP, Núñez L, Ellenbroek BA, Rodriguez de Fonseca F.

Psychopharmacology (Berl). 2009 Nov;206(4):531-49. doi: 10.1007/s00213-009-1612-6. Epub 2009 Jul 24. Review.

PMID:
19629449
16.

Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.

Snider NT, Walker VJ, Hollenberg PF.

Pharmacol Rev. 2010 Mar;62(1):136-54. doi: 10.1124/pr.109.001081. Epub 2010 Feb 4. Review.

17.

At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring.

Alpár A, Di Marzo V, Harkany T.

Biol Psychiatry. 2016 Apr 1;79(7):e33-45. doi: 10.1016/j.biopsych.2015.09.009. Epub 2015 Sep 25. Review.

PMID:
26549491
18.

The evolving role of the endocannabinoid system in gynaecological cancer.

Ayakannu T, Taylor AH, Willets JM, Konje JC.

Hum Reprod Update. 2015 Jul-Aug;21(4):517-35. doi: 10.1093/humupd/dmv022. Epub 2015 May 9. Review.

PMID:
25958409
19.

Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.

Gertsch J.

Planta Med. 2008 May;74(6):638-50. doi: 10.1055/s-2008-1034302. Epub 2008 Feb 14. Review.

PMID:
18275004
20.

Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).

Bossong MG, Jansma JM, Bhattacharyya S, Ramsey NF.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:53-69. doi: 10.1016/j.pnpbp.2013.11.017. Epub 2013 Dec 29. Review.

PMID:
24380726

Supplemental Content

Support Center